Novo Nordisk's CEO is not worried about blockbuster semaglutide drugs being added to Medicare drug pricing negotiations this ...
9h
This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback